Physician profile
Paul Joseph Devlin
NPI 1528457223
$6,128.74
in general payments reported to CMS, 2019-2025
14 companies · $56.53 in 2025
The $56.53 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,049 · 2021: $982 · 2022: $2,155 · 2023: $1,697 · 2024: $190 · 2025: $56.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,943.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,847.25 | 2019-2023 | |
| Abbott Laboratories | $1,252.25 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic, INC. | $804.83 | 2021-2023 | Freestyle, Mosaic, Octopus |
| Abiomed | $452.38 | 2022-2023 | Impella |
| Zimmer Biomet Holdings, INC. | $428.44 | 2019-2022 | |
| Edwards Lifesciences Corporation | $396.72 | 2021-2023 | Konect Resilia |
| Transmedics, INC. | $297.21 | 2022 | |
| Bolton Medical INC | $174.81 | 2023 | Treo Abdominal Stent-Graft System |
| Elutia, INC. | $139.49 | 2022 | |
| Terumo Cardiovascular Systems Corporation | $127.15 | 2024 | Cdi Blood Parameter Monitoring System 550 |
| Davol INC. | $109.11 | 2023 | Progel Applicator Spray Tips |
| Terumo Medical Corporation | $41.40 | 2023 | Angio-Seal |
| Lsi Solutions INC | $35.67 | 2022 | |
| Baxter Healthcare | $22.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Devlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.